|
|
| Research article summary (published 8 Aug 2009): |
Inhibition of platelet-rich arterial thrombus in vivo: acute antithrombotic effect of intravenous HMG-CoA reductase therapy.
Full Abstract
OBJECTIVE: To test the hypothesis that statins will acutely inhibit platelet thrombus formation, intravenous lovastatin was assessed in our well-characterized porcine carotid injury model. METHODS AND RESULTS: The first carotid artery was crush-injured and harvested after 30 minutes. Pigs then received intravenous lovastatin (100 microg/kg bolus+100 microg/kg/h infusion, n=6) or saline (n=11) before injury of the second carotid artery. Thrombus size was quantified by scintillation detection of autologous (111)In-platelets. Sequential carotid injury produced a thrombus more than 50% greater in volume in the second (3149+/-2053 x 10(6)/cm(2)) relative to the first injured artery (2081+/-1552 x 10(6)/cm(2); P=0.04) in control pigs. This augmentation was inhibited by intravenous lovastatin which acutely reduced platelet deposition (944+/-246 x 10(6)/cm(2)) relative to saline control (P=0.02). Flow chamber closure times increased on average by 2.45-fold in response to whole blood lovastatin incubation. Lovastatin (P<0.05) and simvastatin (P<0.05) reduced platelet dense granule secretion in vitro. CONCLUSIONS: Sequential arterial injury augments the thrombotic response suggesting that the propensity for arterial thrombosis is at least partially acquired. This thrombotic augmentation can be acutely attenuated by intravenous lovastatin which may result from a pleiotropic impact on platelet function. These results appear to be a class effect of 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors.
Author information
Author/s: Obi, Chike (C); Wysokinski, Waldemar (W); Karnicki, Krzystof (K); Owen, Whyte G (WG); McBane, Robert D (RD);
Affiliation: University of Pittsburgh School of Medicine, Pittsburgh, Penn., USA.
Journal and publication information
Publication Type: Journal Article
Journal: Arteriosclerosis, thrombosis, and vascular biology (Arterioscler Thromb Vasc Biol), published in United States. (Language: eng)
Reference: 2009-Sep; vol 29 (issue 9) : pp 1271-6
Dates: Created 2009/08/20; Completed 2009/09/08;
PMID: 19667107, status: MEDLINE (last retrieval date: 9/8/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- The relationship between obesity and atherosclerotic progression and prognosis among patients with coronary artery bypass grafts the effect of aggressive statin therapy.
17 Aug 2008 - Potential impact on cardiovascular public health of over-the-counter statin availability.
28 Jan 2006 - By the way, doctor... My brother takes Mevacor and has been told to take the drug at bedtime. But when I started on Lipitor, my doctor said to take the medication at any time of the day. Why the difference?
30 Jul 2001 - Efficacy of three statins at lower maintenance doses.
30 Jan 1999 - The role of intracellular cholesterol on the processing of the beta-amyloid precursor protein.
30 Dec 2002 - A Phase I trial of prolonged administration of lovastatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or of the cervix.
20 Jan 2005 - Cost-effectiveness analysis of simvastatin and lovastatin/extended- release niacin to achieve LDL and HDL goal using NHANES data.
29 Apr 2004 - Platelet hyperactivity and risk of recurrent thrombosis.
3 Oct 2006 - Inhibitory effects of lycopene on in vitro platelet activation and in vivo prevention of thrombus formation.
29 Sep 2005 - Lovastatin enhances gefitinib activity in glioblastoma cells irrespective of EGFRvIII and PTEN status.
18 Jun 2008
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.